Document Detail


In search of preclinical robustness.
MedLine Citation:
PMID:  23023666     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Systematic engagement of statisticians in preclinical research could help address the weaknesses that are undermining the likelihood of subsequent success in drug discovery and development.
Authors:
Ian S Peers; Peter R Ceuppens; Chris Harbron
Related Documents :
25482006 - Highlights of qualitative research articles in bioethics: academic year 2013-2014.
25239566 - Tensions between anonymity and thick description when "studying up" in genetics research.
23884716 - Exploring the diversity of conceptualizations of work (dis)ability: a scoping review of...
23505516 - Mapping systematic reviews on atopic eczema-an essential resource for dermatology profe...
10635506 - Fraud, misconduct or normal science in medical research--an empirical study of demarcat...
18617496 - Patients' refusal to consent to storage and use of samples in swedish biobanks: cross s...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Nature reviews. Drug discovery     Volume:  11     ISSN:  1474-1784     ISO Abbreviation:  Nat Rev Drug Discov     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101124171     Medline TA:  Nat Rev Drug Discov     Country:  England    
Other Details:
Languages:  eng     Pagination:  733-4     Citation Subset:  IM    
Affiliation:
AstraZeneca 13F41 Mereside, Alderley Park, Macclesfield SK10 4TG, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Genomics of sex determination in Drosophila.
Next Document:  Targeting IL-17 and T(H)17 cells in chronic inflammation.